本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NEWAMSTERDAM PHARMA CO NV

19.85
+0.89004.69%
盘后19.850.00000.00%15:40 EDT
成交量:66.66万
成交额:1,302.36万
市值:22.29亿
市盈率:-10.73
高:20.05
开:19.07
低:18.70
收:18.96
数据加载中...
2025/01/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/28

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/10/19

SEC问询函

Form CORRESP - Correspondence
2024/10/18

重要事件披露

Form 8-K - Current report
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/09

重要事件披露

Form 8-K - Current report